Renata Veselská

2.0k total citations
72 papers, 1.5k citations indexed

About

Renata Veselská is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Renata Veselská has authored 72 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 24 papers in Oncology and 14 papers in Cell Biology. Recurrent topics in Renata Veselská's work include Cancer Cells and Metastasis (15 papers), Retinoids in leukemia and cellular processes (13 papers) and Microtubule and mitosis dynamics (8 papers). Renata Veselská is often cited by papers focused on Cancer Cells and Metastasis (15 papers), Retinoids in leukemia and cellular processes (13 papers) and Microtubule and mitosis dynamics (8 papers). Renata Veselská collaborates with scholars based in Czechia, Germany and Portugal. Renata Veselská's co-authors include Jakub Neradil, Jaroslav Štěrba, J. Škoda, Tomáš Loja, Petr Chlapek, Karel Zitterbart, Iva Staniczková Zambo, Olga Krupková, Markéta Hermanová and Pavel Mazánek and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Renata Veselská

68 papers receiving 1.4k citations

Peers

Countries citing papers authored by Renata Veselská

Since Specialization

Citations

This map shows the geographic impact of Renata Veselská's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renata Veselská with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renata Veselská more than expected).

Fields of papers citing papers by Renata Veselská

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renata Veselská. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renata Veselská. The network helps show where Renata Veselská may publish in the future.

Co-authorship network of co-authors of Renata Veselská

This figure shows the co-authorship network connecting the top 25 collaborators of Renata Veselská. A scholar is included among the top collaborators of Renata Veselská based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renata Veselská. Renata Veselská is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Survey on the current practice of research ethics committees in the Czech academic environment: a mixed-methods study 2024 ·BMC Medical Ethics ·Renata Veselská, (unknown), (unknown)	0
2	Emerging roles of prominin-1 (CD133) in the dynamics of plasma membrane architecture and cell signaling pathways in health and disease 2024 ·Cellular & Molecular Biology Letters ·(unknown), Christine A. Fargeas, Renata Veselská, Denis Corbeil, J. Škoda	17
3	Thiosemicarbazones Can Act Synergistically with Anthracyclines to Downregulate CHEK1 Expression and Induce DNA Damage in Cell Lines Derived from Pediatric Solid Tumors 2022 ·International Journal of Molecular Sciences ·(unknown), (unknown), Petr Chlapek, Jakub Neradil, J. Škoda, Renata Veselská	3
4	Thiosemicarbazones and selected tyrosine kinase inhibitors synergize in pediatric solid tumors: NDRG1 upregulation and impaired prosurvival signaling in neuroblastoma cells 2022 ·Frontiers in Pharmacology ·(unknown), (unknown), Petr Chlapek, Jakub Neradil, J. Škoda, Renata Veselská	6
5	Bromodomain 4 inhibition leads to MYCN downregulation in Wilms tumor 2021 ·Pediatric Blood & Cancer ·(unknown), Noah Berlow, Michael V. Ortiz, Filemon S. Dela Cruz, (unknown), (unknown), (unknown), (unknown), Joel Michalek, (unknown), (unknown), (unknown), Brigitte Royer‐Pokora, Renata Veselská, Andrew L. Kung, Charles Keller	8
6	Novel Thiosemicarbazones Sensitize Pediatric Solid Tumor Cell-Types to Conventional Chemotherapeutics through Multiple Molecular Mechanisms 2020 ·Cancers ·(unknown), J. Škoda, Jakub Neradil, (unknown), Petr Chlapek, Jaroslav Štěrba, Des R. Richardson, Renata Veselská	8
7	Prediction of neuroblastoma cell response to treatment with natural or synthetic retinoids using selected protein biomarkers 2019 ·PLoS ONE ·(unknown), Petr Chlapek, Marta Ježová, (unknown), Pavel Mazánek, Jaroslav Štěrba, Renata Veselská	10
8	Comparative Analysis of Putative Prognostic and Predictive Markers in Neuroblastomas: High Expression of PBX1 Is Associated With a Poor Response to Induction Therapy 2019 ·Frontiers in Oncology ·Renata Veselská, Marta Ježová, Michal Kýr, Pavel Mazánek, Petr Chlapek, (unknown), Jaroslav Štěrba	7
9	New inhibitor of the TAp73 interaction with MDM2 and mutant p53 with promising antitumor activity against neuroblastoma 2019 ·Cancer Letters ·Sara Gomes, Liliana Raimundo, Joana Soares, Joana B. Loureiro, Miguel Leão, Helena Ramos, (unknown), Agostinho Lemos, Joana Moreira, Madalena Pinto, Petr Chlapek, Renata Veselská, Emı́lia Sousa, Lucı́lia Saraiva	34
10	Case report: rapid and durable response to PDGFR targeted therapy in a child with refractory multiple infantile myofibromatosis and a heterozygous germline mutation of the PDGFRB gene 2017 ·BMC Cancer ·(unknown), Ondřej Slabý, Jakub Neradil, (unknown), (unknown), (unknown), Marta Ježová, Anna Seehofnerová, Elleni Michu, Renata Veselská, Jaroslav Štěrba	43
11	Cancer stem cell markers in pediatric sarcomas: Sox2 is associated with tumorigenicity in immunodeficient mice 2016 ·Tumor Biology ·J. Škoda, (unknown), Tomáš Loja, Iva Staniczková Zambo, Jakub Neradil, Peter Múdrý, Karel Zitterbart, Markéta Hermanová, Aleš Hampl, Jaroslav Štěrba, Renata Veselská	29
12	Co-Expression of Cancer Stem Cell Markers Corresponds to a Pro-Tumorigenic Expression Profile in Pancreatic Adenocarcinoma 2016 ·PLoS ONE ·J. Škoda, Markéta Hermanová, Tomáš Loja, Pavel Němec, Jakub Neradil, Petr Karásek, Renata Veselská	36
13	Overexpression of the ∆Np73 isoform is associated with centrosome amplification in brain tumor cell lines 2015 ·Tumor Biology ·(unknown), Jakub Neradil, Karel Zitterbart, Jaroslav Štěrba, Renata Veselská	8
14	Atypical nuclear localization of CD133 plasma membrane glycoprotein in rhabdomyosarcoma cell lines 2015 ·International Journal of Molecular Medicine ·(unknown), Jakub Neradil, J. Škoda, Josef Jaroš, Aleš Hampl, Jaroslav Štěrba, Renata Veselská	19
15	New mechanisms for an old drug; DHFR- and non-DHFR-mediated effects of methotrexate in cancer cells. 2012 ·PubMed ·Jakub Neradil, Gabriela Mladonická Pavlasová, Renata Veselská	48
16	Nestin expression in human tumors and tumor cell lines. 2010 ·Neoplasma ·Olga Krupková, Tomáš Loja, Iva Staniczková Zambo, Renata Veselská	91
17	Low-level copy number changes of MYC genes have a prognostic impact in medulloblastoma 2010 ·Journal of Neuro-Oncology ·Karel Zitterbart, (unknown), (unknown), (unknown), Iva Staniczková Zambo, (unknown), (unknown), Vladimíra Vranová, (unknown), (unknown), Zdeněk Pavelka, Renata Veselská, Petr Kuglík, Jaroslav Štěrba	16
18	Nestin expression in osteosarcomas and derivation of nestin/CD133 positive osteosarcoma cell lines 2008 ·BMC Cancer ·Renata Veselská, Markéta Hermanová, Tomáš Loja, Petr Chlapek, Iva Staniczková Zambo, Karel Veselý, Karel Zitterbart, Jaroslav Štěrba	49
19	The optimization of sample treatment for spectral karyotyping with applications for human tumour cells 2007 ·Cytogenetic and Genome Research ·Tomáš Loja, Petr Kuglík, Alexandra Oltová, (unknown), Karel Zitterbart, Viera Bajčiová, Renata Veselská	3
20	Reaction of the Skin Fibroblast Cytoskeleton to Micromanipulation Interventions 2001 ·Journal of Structural Biology ·Renata Veselská, (unknown)	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact